EBITDA for Merck & Co. (MRK)
According to Merck & Co.'s latest reported financial statements, the company's current EBITDA (TTM) is $26.31B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
MRK
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
$26.31B
YoY change
-1.3%
5Y CAGR
+20.0%
Peak year (2024)
$25.71B
Cumulative EBITDA
$410.77B
EBITDA history chart for Merck & Co. (MRK) from 1985 to 2025
EBITDA history table for Merck & Co. (MRK) from 1985 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY |
|---|---|---|---|---|
| 2025 | $25.36B | -1.3% | ||
| 2024 | $25.71B | +272.2% | ||
| 2023 | $6.91B | -67.6% | ||
| 2022 | $21.32B | +19.1% | ||
| 2021 | $17.90B | +75.8% | ||
| 2020 | $10.18B | -10.5% | ||
| 2019 | $11.37B | -18.7% | ||
| 2018 | $13.99B | +17.1% | ||
| 2017 | $11.95B | +10.4% | ||
| 2016 | $10.82B | -13.1% | ||
| 2015 | $12.45B | -49.6% | ||
| 2014 | $24.71B | +85.3% | ||
| 2013 | $13.33B | -18.8% | ||
| 2012 | $16.43B | +6.3% | ||
| 2011 | $15.46B | +58.5% | ||
| 2010 | $9.75B | -46.8% | ||
| 2009 | $18.33B | +55.1% | ||
| 2008 | $11.81B | +55.3% | ||
| 2007 | $7.61B | +27.7% | ||
| 2006 | $5.96B | -21.3% | ||
| 2005 | $7.57B | -7.8% | ||
| 2004 | $8.21B | -16.9% | ||
| 2003 | $9.88B | -4.2% | ||
| 2002 | $10.32B | -0.9% | ||
| 2001 | $10.41B | -2.6% | ||
| 2000 | $10.69B | +18.0% | ||
| 1999 | $9.06B | +22.5% | ||
| 1998 | $7.39B | +10.3% | ||
| 1997 | $6.70B | +13.3% | ||
| 1996 | $5.91B | +12.3% | ||
| 1995 | $5.26B | -0.3% | ||
| 1994 | $5.28B | +22.8% | ||
| 1993 | $4.30B | +12.8% | ||
| 1992 | $3.81B | +13.0% | ||
| 1991 | $3.37B | +16.1% | ||
| 1990 | $2.91B | +18.2% | ||
| 1989 | $2.46B | +18.6% | ||
| 1988 | $2.07B | +31.2% | ||
| 1987 | $1.58B | +27.9% | ||
| 1986 | $1.24B | +20.8% | ||
| 1985 | $1.02B | — |
EBITDA values are taken from Merck & Co.'s reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual EBITDA for Merck & Co. (MRK) came in at $25.36B – edged down 1.3% year-over-year.
Merck & Co. EBITDA compound annual growth for the 2020–2025 (5 years) window is +20.0%, with the latest reading among the more recent periods of the dataset.
Between 2024 and 2025, Merck & Co. EBITDA edged down 1.3%, falling from $25.71B to $25.36B.
The dataset's maximum EBITDA sits at $25.71B (2024); the minimum reading of $1.02B dates to 1985.
Merck & Co. (MRK) sits 4th of 8 Healthcare peers we track on this metric, against a peer median of $21.44B.
Merck & Co. EBITDA by Year
Merck & Co. EBITDA 2025: $25.36B
Merck & Co. EBITDA in 2025 was $25.36B, edged down 1.3% below 2024.
Merck & Co. EBITDA 2024: $25.71B
Merck & Co. EBITDA in 2024 was $25.71B, surged 272.2% from 2023. This figure represents the highest annual value in the available history.
Merck & Co. EBITDA 2023: $6.91B
Merck & Co. EBITDA in 2023 was $6.91B, plunged 67.6% below 2022.
Merck & Co. EBITDA 2022: $21.32B
Merck & Co. EBITDA in 2022 was $21.32B, grew 19.1% from 2021.
Merck & Co. EBITDA 2021: $17.90B
Merck & Co. EBITDA in 2021 was $17.90B.
See more financial history for Merck & Co. (MRK).
Sector peers — EBITDA
Companies in the same sector as Merck & Co., ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $156.73B | Healthcare |
| Johnson & Johnson (JNJ) | $41.05B | Healthcare |
| Eli Lilly and Company (LLY) | $27.94B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $23.06B | Healthcare |
| AstraZeneca PLC (AZN) | $19.83B | Healthcare |
| AbbVie Inc. (ABBV) | $17.63B | Healthcare |
| Amgen Inc. (AMGN) | $15.84B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $11.47B | Healthcare |
Frequently asked questions
What is Merck & Co.'s EBITDA?
- Latest reported EBITDA for Merck & Co. (MRK) is $26.31B (period ending December 31, 2025).
How has Merck & Co. EBITDA changed year-over-year?
- Merck & Co. (MRK) EBITDA changed -1.3% year-over-year on the latest annual filing.
What is the long-term growth rate of Merck & Co. EBITDA?
- Merck & Co. (MRK) EBITDA compound annual growth rate is +20.0% over the most recent 5 years available.
When did Merck & Co. EBITDA hit its highest annual value?
- Merck & Co. EBITDA reached its highest annual value of $25.71B in 2024.
What was Merck & Co. EBITDA in 2024?
- Merck & Co. (MRK) EBITDA in 2024 was $25.71B.
What was Merck & Co. EBITDA in 2025?
- Merck & Co. (MRK) EBITDA in 2025 was $25.36B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
MRK Overview
Company profile, financial tools, and key metrics
MRK Revenue Counter
Earns $2,061 every second. See per minute, hour, and day.
MRK Earnings Counter
Earns $578.83 per second net profit. See per minute, hour, and day.
MRK Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
MRK What If Invested
What if you had invested $1,000? See historical returns from any date.
MRK How It Makes Money
Discover visual breakdown of $65.01B in revenue — where it comes from and where it goes.
MRK Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
MRK Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
MRK Daily Price Character
Steady · 48.2% historical win rate (green days). Streaks & record days.
MRK Buybacks
2.39% TTM buyback yield. Shareholder yield & SBC comparison.
MRK Stock Split History
7 splits on record. Dates, ratios, and cumulative multiple.
MRK Dividend Profile
Yield: 2.99%. Safety: 8/8. See full history.
MRK Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
MRK Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.